key: cord-0993517-y4003zzd
authors: Vervoort, Dominique; Ma, Xiya; Luc, Jessica G Y
title: COVID-19 Pandemic: A Time for Collaboration and A Unified Global Health Front
date: 2020-06-27
journal: Int J Qual Health Care
DOI: 10.1093/intqhc/mzaa065
sha: ef5396334647e3043f18330fabf7e6b585dd9511
doc_id: 993517
cord_uid: y4003zzd

Coronavirus disease 2019 (COVID-19) has, in the span of weeks, immobilized entire countries and mobilized leading institutions worldwide in a race towards treatments and preventions. While several solutions such as telemedicine and online education platforms have been implemented to reduce human contact and further transmission, countries need to favour collectivism both within and beyond their borders. Inspired by experiences of previous outbreaks such as SARS in 2003 and Ebola in 2014–2015, global solidarity is a must in order to prevent further morbidity and mortality. Examples in leadership and collaborations ranging from research funds from the Bill and Melinda Gates Foundation to mask donations by the Jack Ma Foundation should be celebrated as examples to follow. Open communication and transparency will be crucial in monitoring the evolution of the disease in the global effort of flattening the curve. This crisis will challenge the integrity and fuel innovation of health systems worldwide, whilst posing a new quality chasm that warrants increased recognition.

On May 27th, 2020, over five million confirmed cases and 350,000 deaths were recorded due to the coronavirus disease 2019 . 1 The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, has led dozens of countries to sequentially decide to enter lockdown to the extent that a majority of the world's population was and is subject to shelter-in-place. While the development of vaccines and targeted pharmacological treatments are months away, decisive public health leadership is necessary to adequately mitigate the exponential increase in COVID-19 cases by flattening the epidemiological curve and by preparing for future waves and the post-COVID-19 era. 2 Many solutions have already been proposed and put in place to tackle the growing strain on health systems around the world. Telemedicine is used to assess suspected cases prior to relocating them to health care facilities to get them tested in the interest of resource allocation. 3 This form of "forward triage" limits the influx of patients to emergency department and primary care centers, limiting further spread and pressure on providers. Rigorous social distancing is recommended in heavily-hit countries in East Asia, Europe, and North America, as countries closed schools and businesses, and social events and sports leagues were postponed. Meanwhile, classes and job interviews are conducted through virtual platforms as preventive self-isolation ramped up across populations.

The SARS and Ebola outbreaks in the past two decades have made countries around the world restructure emergency preparedness and disease surveillance

programs to mitigate potential future epidemics. In 2003, at the peak of the SARS outbreak, collaborative efforts between China and the rest of the world rapidly ensured the isolation, testing, and mitigation of SARS-CoV, containing SARS within months. 4 Between 2014 and 2015, the Ebola epidemic in West Africa led to nearly 30,000 cases with a 40% case fatality rate. 5 To respond to this surge in cases after previous, smaller outbreaks, regional travel restrictions and international collaborations between public health departments and the World Health Organization Nigeria's exceptional contact tracing response to their first cases led to a quick halt in national spread despite its large population. In Taiwan, temperature checks upon arrival were instituted early January after discovering an unknown surge in "severe flu" cases in mainland China. 6 South Korea approached the pandemic in a proactive way with broad testing, rigorous contact tracing, and reinforced quarantines, resulting in a rapidly decreasing number of new cases and a remarkably low case fatality rate. 7 In Hong Kong, home to some of the world's most densely populated areas, social distancing measures were put in place early and life continues as nearnormal.

These lessons are now of use in countries where the surge of COVID-19 cases is happening live or have recently peaked, and essential items such as 

communities, or being African American or Hispanic. 9,10 Lastly, the fast-tracking of trials, accelerated peer review, surge of preprints, and fear-mongering media have led to an increase in use of off-label and unproven drugs (e.g., hydroxychloroquine).

This resulted in adverse clinical outcomes, and unwarranted ceasing of necessary and potentially protective medication (e.g., angiotensin converting enzym inhibitors). 11 This proves the need to maintain rigorous methodological standards, rather than merely bypassing conventional approaches to accelerate research in times of uncertainty.

In turn, although most low-and middle-income countries are yet to be struck by the substantial numbers of COVID-19 cases seen in high-income countries, the potential impact on growing and fragile health systems may have unprecedented consequences. In the past decades, development aid for health has mostly focused on vertical disease silos, whereas health systems strengthening interventions have only recently gained attention. 12 Nevertheless, lessons may be drawn from the SARS and Ebola outbreaks and sustained care delivery for emergency cases and progressive diseases in the light of resource constraints in low-and middle-income countries across the globe.

With the global peak of the COVID-19 pandemic impending, international collaborations are necessary more than ever. China's prescient initiative to support Italy by providing experienced health care professionals, 1,000 ventilators, 100,000 masks, 20,000 protective equipment, and 50,000 test kits sets an example of human solidarity for other countries to follow in the near future. This may be further Science and Engineering to track COVID-19 cases globally.

As the world braces for a miracle cure or vaccine, we cannot allow a decline in scientific rigor or inflation of the potential value of a therapy. At any time, our patients deserve safe and effective evidence-based therapies for COVID-19.

Researchers are responsible for the ethical conduct of studies and need to ensure that consent is safeguarded, appropriate data analysis and reporting was conducted, the expected gain is commensurate with therapeutic risks, and fair subject selection takes place. Similarly, journals are responsible for ensuring the ethical conduct of the research that they publish and ought to publish both positive and negative studies as they both have value in the treatment of patients with COVID-19. Hereby, a fine balance needs to be struck between accelerating the publication process-to better and more quickly inform COVID-19-specific medical care-which is currently being done by major journals, and maintaining academic integrity and rigor. Furthermore, to mitigate harm to population health, physicians have a role to combat misinformation to ensure the credibility and accuracy of medical information that is disseminated, refute misinformation, and promote evidence-based practice.

History lessons and trickle-up health systems innovation show promising early results, encouraging state and public health leaders to look beyond borders.

Flattening the curve globally will require international, multisectoral collaborative efforts to ensure that countries' health systems are able to maintain sufficient capacity to address the flux of complicated COVID-19 cases and protect the vulnerable and elderly in the world's population. Only by learning from the global experience in our battle against a virus that respects no borders, can we honour the lives already lost and implement life-saving measures for current and future patients. Hospitalizations and Deaths Across New York City Boroughs. JAMA. April

An interactive web-based dashboard to track COVID-19 in real time

Assessing the Collateral Damage of the Novel Coronavirus: A Call to Action for the Post-COVID-19 Era

Supporting the Health Care Workforce During the COVID-19 Global Epidemic

Can we contain the COVID-19 outbreak with the same measures as for SARS?

The Ebola epidemic: a global health emergency

Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing

National Response to COVID-19 in the Republic of Korea and Lessons Learned for Other Countries

Part of the Cure or Spreader of Disease?

Treating COVID-19 in Rural America. J Rural Heal Off J Am Rural Heal Assoc Natl Rural Heal Care Assoc

Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19

Past, present, and future of global health financing: a review of development assistance, government, out-ofpocket, and other private spending on health for 195 countries